Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Advanced human skin models improve drug development and could replace animal testing.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

Hair analysis for drugs needs a better understanding of how drugs enter hair, considering factors like hair structure and pigmentation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Optimized film improves finasteride skin absorption and treatment efficiency.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

There is no significant link between male pattern baldness and insulin resistance.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Lower ghrelin levels and certain gene variations may increase acne risk.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.